Enbiosis

Enbiosis is a biotechnology company combining whole-genome gut microbiome sequencing with artificial intelligence to generate personalised nutrition, dietary, and supplement recommendations for patients with gastrointestinal disorders.

Its B2B platform is used by healthcare professionals including gastroenterologists and dietitians to guide microbiome-targeted interventions, with a primary focus on irritable bowel syndrome and chronic constipation.

The company also develops AI-designed nutraceutical formulations for supplement manufacturers. Clinical outcomes are supported by publications in peer-reviewed gastroenterology journals.